E.g., 10/27/2020
E.g., 10/27/2020
Title Credit Typesort ascending Specialty Event date
Lessons Learned from Newborn Screening for Pompe Disease and Mucopolysaccharidosis Type I: Early Intervention Influences Outcomes
Online Presentation

Covering Pompe disease (PD) and mucopolysaccharidosis type I (MPS I), this activity will feature 3 expert faculty and be delivered in a dynamic plenary and case-based format to maximize interactivity, engagement, and retention.
    • 1.50 AMA PRA Category 1 Credit™ credits
    • 1.50 Participation credits
Enduring Internal Medicine Ongoing
How Is PAD Treated After a Surgical Procedure?
Patient Education

The goal of this patient education activity is to inform you about how PAD is treated after a procedure so that you can discuss your treatment plan with your doctor or healthcare provider.
Enduring Other Ongoing
Treating Complex Cases of Arterial Disease: How to Reduce Risk for CV Events?
Online Presentation

The goal of this activity is to provide clinicians who treat patients with arterial disease with the latest scientific data and guideline-based clinical concepts to optimize patient care.
    • 1.00 AMA PRA Category 1 Credit™ credit
    • 1.00 Participation credit
Enduring Internal Medicine Ongoing
Celiac Disease in the 21st Century: Understanding the Latest Management and Treatment Options for CD
Online Presentation
 
This is an online CME-certified educational intervention designed to address the identified gaps in the care of patients with celiac disease. The online format will allow for convenient access and thus reach a broad audience of medical professionals.
Enduring Internal Medicine Ongoing
Digging Deep in Data: Comparing Renal Outcomes From Trials on SGLT2 Inhibitors
Online Presentation

The goal of this activity is to improve awareness of data on the renoprotective effects of SGLT2 inhibitors in people with type 2 diabetes (T2D).
    • 0.50 AMA PRA Category 1 Credit™ credits
    • 0.50 Participation credits
Enduring Internal Medicine Ongoing
DOACs, CAD, and PCI: How to Treat?
Online Presentation

The goal of this activity is to learn about the latest clinical data and guidelines supporting the use of factor Xa inhibitor therapy for treatment of patients with coronary artery disease (CAD) who are undergoing percutaneous coronary intervention (PCI).
    • 0.50 AMA PRA Category 1 Credit™ credits
    • 0.50 Participation credits
Enduring Internal Medicine Ongoing
Episode 1: VTE Risk Assessment in Medically Ill Patients: What Does the Latest Evidence Suggest?
Online Presentation

The goal of this activity is to review the use of venous thromboembolism (VTE) risk stratification strategies in medically-ill hospitalized patients.
    • 0.25 AMA PRA Category 1 Credit™ credits
    • 0.25 Participation credits
    • 0.25 Nursing Contact Hours credits
Enduring Internal Medicine Ongoing
Transitioning From Acute to Chronic Care in PAD: From Latest Evidence to Clinical Care
Online Presentation

The goal of this activity is to inform participants about the latest clinical data regarding patients with peripheral artery disease (PAD) and to improve the use of antithrombotic therapy in these patients.
    • 0.50 AMA PRA Category 1 Credit™ credits
    • 0.50 Participation credits
Enduring Internal Medicine Ongoing
Antithrombotic Therapy in Patients With Polyvascular Disease: Practice Your Skills
Online Interactive Simulation

The goal of this activity is to utilize evidence-based strategies for the assessment and diagnosis of polyvascular disease and to provide comprehensive management for patients requiring antithrombotic therapy.
    • 1.00 AMA PRA Category 1 Credit™ credit
    • 1.00 Participation credit
    • 1.00 Nursing Contact Hours credit
Enduring Internal Medicine Ongoing
CCS Guidelines and Treatment of CAD: Where Do DOACs Fit In?
Online Presentation

The goal of this activity is to learn about the latest recommendations on the use of antithrombotic therapy for treatment of patients with chronic coronary syndrome (CCS).
    • 0.50 AMA PRA Category 1 Credit™ credits
    • 0.50 Participation credits
    • 0.50 Nursing Contact Hours credits
Enduring Internal Medicine Ongoing
What’s New in PAD: Factor Xa Inhibitors and Antiplatelet Postprocedure
Online Presentation

The goals of this activity are to inform participants about the latest clinical data regarding factor Xa inhibitor therapy in patients with peripheral artery disease (PAD) and to improve the use of antithrombotic therapy in patients with PAD who have undergone recent peripheral revascularization.
    • 0.50 AMA PRA Category 1 Credit™ credits
    • 0.50 Participation credits
Enduring Internal Medicine Ongoing
Pursuing Excellence: Interdepartmental Quality & Safety
Online Modules

University of Chicago Medicine is dedicate to continually improving the quality of care available to patients. This series of engaging educational modules will provide you with valuable information that will help you pursue excellence in patient care at UCM!
    • 2.50 AMA PRA Category 1 Credit™ credits
    • 2.50 Participation credits
    • 2.50 ABIM credits
Enduring Internal Medicine Ongoing
Managing Complicated Patients with T2D
Online Interactive Simulation

The goal of this activity is to utilize evidence-based strategies for the assessment and diagnosis of polyvascular disease and to provide comprehensive management for patients requiring antithrombotic therapy.
    • 1.00 AMA PRA Category 1 Credit™ credit
    • 1.00 Participation credit
Enduring Internal Medicine Ongoing
Episode 5: DOACs and VTE Prevention in Acutely Ill Medical Patients: Implications on Arterial Events
Online Presentation

The goal of this activity is to provide the latest information on the effects of direct oral anticoagulants (DOACs) on both arterial and venous thromboembolic events and how this impacts patient morbidity and mortality.
    • 0.25 AMA PRA Category 1 Credit™ credits
    • 0.25 Participation credits
    • 0.25 Nursing Contact Hours credits
Enduring Internal Medicine Ongoing
Factor Xa Inhibitors in CAD and Diabetes: Evaluating the Latest Data
Online Presentation

The goal of this activity is to learn about the latest clinical trial data on the use of combination anticoagulant and antiplatelet therapy in patients with CAD and diabetes.
    • 0.50 AMA PRA Category 1 Credit™ credits
    • 0.50 Participation credits
    • 0.50 Nursing Contact Hours credits
Enduring Internal Medicine Ongoing

Pages